Barclays PLC Jounce Therapeutics, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
SELL
$0.9 - $1.85 $14,915 - $30,660
-16,573 Reduced 43.53%
21,498 $39,000
Q4 2022

Feb 13, 2023
BUY
$0.64 - $1.99 $6,097 - $18,960
9,528 Added 33.38%
38,071 $43,000
Q3 2022

Nov 03, 2022
SELL
$2.73 - $4.92 $659,958 - $1.19 Million
-241,743 Reduced 89.44%
28,543 $66,000
Q2 2022

Aug 12, 2022
SELL
$2.8 - $7.67 $530,944 - $1.45 Million
-189,623 Reduced 41.23%
270,286 $819,000
Q1 2022

May 16, 2022
SELL
$6.01 - $8.54 $1.55 Million - $2.21 Million
-258,710 Reduced 36.0%
459,909 $3.12 Million
Q4 2021

Feb 14, 2022
BUY
$7.11 - $9.64 $4.82 Million - $6.54 Million
678,473 Added 1690.01%
718,619 $6 Million
Q3 2021

Nov 09, 2021
SELL
$5.04 - $8.73 $12,055 - $20,882
-2,392 Reduced 5.62%
40,146 $298,000
Q2 2021

Aug 13, 2021
BUY
$6.58 - $10.66 $126,309 - $204,629
19,196 Added 82.24%
42,538 $290,000
Q1 2021

May 13, 2021
BUY
$6.73 - $13.87 $119,612 - $246,511
17,773 Added 319.14%
23,342 $239,000
Q4 2020

Feb 11, 2021
SELL
$6.37 - $10.33 $18,046 - $29,264
-2,833 Reduced 33.72%
5,569 $39,000
Q3 2020

Nov 12, 2020
SELL
$4.58 - $10.95 $5,193 - $12,417
-1,134 Reduced 11.89%
8,402 $68,000
Q2 2020

Aug 12, 2020
BUY
$4.17 - $7.58 $16,450 - $29,903
3,945 Added 70.56%
9,536 $66,000
Q1 2020

May 13, 2020
SELL
$2.91 - $8.7 $31,788 - $95,038
-10,924 Reduced 66.15%
5,591 $26,000
Q4 2019

Feb 10, 2020
BUY
$2.81 - $9.21 $15,674 - $51,373
5,578 Added 51.0%
16,515 $144,000
Q3 2019

Nov 14, 2019
SELL
$3.33 - $4.93 $8,521 - $12,615
-2,559 Reduced 18.96%
10,937 $37,000
Q2 2019

Aug 14, 2019
SELL
$4.3 - $6.73 $72,558 - $113,562
-16,874 Reduced 55.56%
13,496 $67,000
Q1 2019

May 15, 2019
SELL
$3.43 - $6.87 $29,374 - $58,834
-8,564 Reduced 22.0%
30,370 $189,000
Q4 2018

Feb 14, 2019
SELL
$2.69 - $6.71 $67,519 - $168,421
-25,100 Reduced 39.2%
38,934 $131,000
Q3 2018

Nov 14, 2018
BUY
$6.5 - $8.37 $88,049 - $113,380
13,546 Added 26.83%
64,034 $415,000
Q2 2018

Aug 14, 2018
SELL
$7.27 - $21.88 $169,354 - $509,694
-23,295 Reduced 31.57%
50,488 $387,000
Q1 2018

May 15, 2018
BUY
$13.4 - $28.4 $923,099 - $1.96 Million
68,888 Added 1407.31%
73,783 $1.65 Million
Q4 2017

Feb 14, 2018
BUY
$12.52 - $17.82 $2,466 - $3,510
197 Added 4.19%
4,895 $62,000
Q3 2017

Nov 14, 2017
BUY
$11.17 - $16.99 $52,476 - $79,819
4,698
4,698 $74,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email